New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
08:28 EDTRGDORegado Biosciences downgraded to Underperform from Outperform at Wedbush
Wedbush downgraded Regado Biosciences two notches to Underperform after the Data Safety Monitoring Board initiated an unplanned review of data from the company's blood clot treatment trial.
News For RGDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
07:31 EDTRGDORegado Biosciences appoints Michael Metzger CEO
Regado Biosciences announced the appointment of Michael Metzger, President of Regado, to the additional post of CEO and as a member of the board effective immediately. Metzger previously served as president and chief operating officer of Regado. He replaces David Mazzo, who has resigned from the company.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use